Skip to main content

Toxic Epidermal Necrolysis clinical trials at UC Davis
1 research study open to eligible people

  • A Study of Experimental Treatment With Clobetasol for Stevens-Johnson’s Syndrome

    “Topical ointment for the treatment of Stevens-Johnson’s Syndrome”

    open to eligible people ages 7-85

    The primary objectives of this study are to investigate the efficacy and safety of topical steroid ointment (clobetasol 0.05%) for the treatment of the cutaneous manifestations of toxic epidermal necrolysis (TEN).

    Sacramento, California

Last updated: